Combining two precision medicines can treat drug-resistant cancers 15 Sep 2020 Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows. Find out more Show/Hide
Breast cancer drug capivasertib enters major trial 24 Jun 2020 A major phase III trial of capivasertib, a cancer drug discovered following collaborative work between The Institute of Cancer Research, London, and partners, has begun in breast cancer. Find out more Show/Hide